Last year the ACR’s nonpartisan political action committee, RheumPAC, raised nearly $150,000 from individual contributors. Starting in 2019, the addition of the RheumPAC Advocacy Fund, where rheumatology practices and state societies can contribute corporate dollars, is expected to support RheumPAC fundraising efforts in an effort to surpass this dollar amount, giving rheumatology an even stronger…
Carina Stanton, BSJ, MA, is a freelance science journalist based in Denver. She has been writing about science for more than 16 years, covering a range of healthcare topics, including rheumatology, surgery, nursing and executive leadership. Her work has appeared in newspapers, newsletters, trade and consumer magazines, books and peer-reviewed journals. Carina has also covered a range of other science news topics, including environmental science, marine biology and archaeology. She has conducted her own research in historical archaeology in Great Britain and Scotland and worked on dig sites in Northern Ireland and Wales. As a former mass media science and engineering fellow for the American Association for the Advancement of Science, Carina is inspired to advance the public understanding of science. When she is not working indoors, Carina is happy spending time outside with her husband and two young children to hike, mountain bike and help her children grow their passion for nature.
Articles by Carina Stanton
3 Tips to Optimize Practice Performance
Rheumatologists can build resilience through recovery and reframing, transforming stress so that it enhances performance…
History of Depression Is a Risk Factor for SLE in Women
Results from a 20-year, cohort study add to the evidence that depression increases the risk of developing an autoimmune disease, specifically SLE in women. Lead investigator Andrea Roberts, PhD, says, “There may be direct biological effects of depression that increase the risk of autoimmune disease.”…
The Effects of Early RA Treatment on CVD
New research exploring the effects of etanercept on cardiovascular disease in treatment-naive, early RA patients suggests a treatment advantage with etanercept, a TNF inhibitor and methotrexate over treatment with methotrexate and a conventional synthetic disease-modifying anti-rheumatic drug…
Large-Vessel Involvement Is an Independent Risk Factor Predicting GCA Mortality
At diagnosis, temporal artery biopsy results and large-vessel involvement of patients with giant cell arteritis may be stronger predictors of mortality than cardiovascular risk factors…
Leadership Support for Division Directors
The ACR has elected a small group of division directors from across the country to serve on the Division Directors Special Committee. The goals of this committee: to better understand the needs of academic rheumatology programs and share with these programs new resources from the ACR and other organizations to support the needs of those…
B Cell-Directed Therapy May Delay RA Development in High-Risk Patients
New evidence from a clinical trial of rituximab has identified the pathogenetic role of B cells in the earliest, pre-arthritis stage of autoantibody-positive RA…
OA Patient-Reported Outcomes Positive for Intra-Articular Injection
In a recent Phase 2 clinical trial, patient-perceived pain and function measures improved with SM04690, an injectable, disease-modifying osteoarthritis treatment currently in development…
Tofacitinib Shows Early Potential for Treating Dermatomyositis
A proof-of-concept study including 10 patients treated for dermatomyositis with tofacitinib, an FDA-approved drug for RA and psoriatic arthritis, shows strong clinical efficacy…
A Step Further: Results from the 1st ACR/ARHP Annual Meeting Walking Challenge
With more than 152,000 taken steps in four days, top honors in the first-ever ACR/ARHP Annual Meeting Walking Challenge go to Mark Phelan, MD…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 15
- Next Page »